Unaffected Arm Muscle Hypercatabolism in Dysphagic Subacute Stroke Patients: The Effects of Essential Amino Acid Supplementation
Table 4
Amino acid arterial concentrations and A − V differences found in the two patient subgroups randomized to receive treatment (EAAs) or placebo, both at admission and discharge from rehabilitation.
Amino acid profiles (mol/L)
Admission
Discharge
∧Trend over time level) interaction
Placebo )
EAAs )
value
Placebo )
EAAs )
Aspartate
A
A − V
Glutamate
A
A − V
Histidine
A
A − V
Asparagine
A
A − V
Serine
A
A − V
Glutamine
A
A − V
3-Methylhistidine
A
A − V
Arginine
A
A − V
Citrulline
A
A − V
Glycine
A
A − V
*Threonine
A
A − V
Alanine
A
A − V
Taurine
A
A − V
Tyrosine
A
A − V
*°Valine
A
A − V
*Methionine
A
A − V
*Tryptophan
A
A − V
*Phenylalanine
A
A − V
*°Isoleucine
A
A − V
*°Leucine
A
A − V
Ornithine
A
A − V
*Lysine
A
A − V
Total-amino acids
A
A − V
*EAAs
A
A − V
°BCAAs
A
A − V
Data are expressed as mean ± standard deviation (SD). Statistical analysis: unpaired -test; ∧repeated measures analysis of variance. Trend over time: interaction differences in trends between groups. *Essential amino acids (EAAs); °branched chain amino acids (BCAAs).